Skip to main content
An official website of the United States government

HyperCVAD regimen

View Patient Information
A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone, administered on a hyperfractionated schedule that is used to treat adult acute lymphoblastic leukemia (ALL) or Burkitt-type ALL and adult small non-cleaved cell (Burkitt) lymphoma, AIDS-related B-cell lymphomas, blastic plasmacytoid dendritic cell neoplasm (BPDCN) and T-cell lymphomas.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Hyper-CVAD regimen
hyperfractionated cyclophosphamide-vincristine-adriamycin-dexamethasone regimen
Abbreviation:HyperCVAD
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search